These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17150599

  • 21. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties.
    Chaloin L, Vidal P, Lory P, Méry J, Lautredou N, Divita G, Heitz F.
    Biochem Biophys Res Commun; 1998 Feb 13; 243(2):601-8. PubMed ID: 9480855
    [Abstract] [Full Text] [Related]

  • 22. Gene inhibition using antisense oligodeoxynucleotides.
    Wagner RW.
    Nature; 1994 Nov 24; 372(6504):333-5. PubMed ID: 7969490
    [Abstract] [Full Text] [Related]

  • 23. Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs.
    Blagosklonny MV, Neckers LM.
    Anticancer Drugs; 1994 Aug 24; 5(4):437-42. PubMed ID: 7949248
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of human telomerase activity by peptide nucleic acids.
    Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR.
    Nat Biotechnol; 1996 May 24; 14(5):615-9. PubMed ID: 9630953
    [Abstract] [Full Text] [Related]

  • 25. Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.
    Ying TH, Hsieh YH, Hsieh YS, Liu JY.
    Cell Biol Int; 2008 Feb 24; 32(2):210-6. PubMed ID: 17950002
    [Abstract] [Full Text] [Related]

  • 26. Antisense sequence-directed cross-linking of DNA oligonucleotides by mitomycin C.
    Maruenda H, Tomasz M.
    Bioconjug Chem; 1996 Feb 24; 7(5):541-4. PubMed ID: 8889014
    [Abstract] [Full Text] [Related]

  • 27. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH, Stein DA, Kroeker AD, Hatlevig SA, Iversen PL, Moulton HM.
    Bioconjug Chem; 2005 Feb 24; 16(4):959-66. PubMed ID: 16029037
    [Abstract] [Full Text] [Related]

  • 28. Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.
    Hélin V, Gottikh M, Mishal Z, Subra F, Malvy C, Lavignon M.
    Biochem Pharmacol; 1999 Jul 01; 58(1):95-107. PubMed ID: 10403523
    [Abstract] [Full Text] [Related]

  • 29. Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O.
    Barry EL, Gesek FA, Friedman PA.
    Biotechniques; 1993 Dec 01; 15(6):1016-8, 1020. PubMed ID: 8292333
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y, Kondo S.
    Methods Mol Biol; 2007 Dec 01; 405():97-112. PubMed ID: 18369820
    [Abstract] [Full Text] [Related]

  • 32. Oligonucleotides conjugated to natural lipids: synthesis of phosphatidyl-anchored antisense oligonucleotides.
    Chillemi R, Greco V, Nicoletti VG, Sciuto S.
    Bioconjug Chem; 2013 Apr 17; 24(4):648-57. PubMed ID: 23451795
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
    Reed MW, Fraga D, Schwartz DE, Scholler J, Hinrichsen RD.
    Bioconjug Chem; 1995 Apr 17; 6(1):101-8. PubMed ID: 7711095
    [Abstract] [Full Text] [Related]

  • 34. Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
    Kraemer K, Fuessel S, Meye A.
    Methods Mol Biol; 2007 Apr 17; 405():9-22. PubMed ID: 18369813
    [Abstract] [Full Text] [Related]

  • 35. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.
    Chen CP, Zhang LR, Peng YF, Wang XB, Wang SQ, Zhang LH.
    Bioconjug Chem; 2003 Apr 17; 14(3):532-8. PubMed ID: 12757376
    [Abstract] [Full Text] [Related]

  • 36. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM.
    Bioconjug Chem; 2007 Apr 17; 18(1):50-60. PubMed ID: 17226957
    [Abstract] [Full Text] [Related]

  • 37. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
    Liu Y, Franzen S.
    Bioconjug Chem; 2008 May 17; 19(5):1009-16. PubMed ID: 18393455
    [Abstract] [Full Text] [Related]

  • 38. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
    Mok H, Park JW, Park TG.
    Bioconjug Chem; 2007 May 17; 18(5):1483-9. PubMed ID: 17602578
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.